No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DSGX240517C95000
- 1.87
- -1.23-39.68%
15min DelayClose May 15 16:00 ET
1.87High1.87Low
1.87Open3.10Pre Close2 Volume172 Open Interest95.00Strike Price374.00Turnover50.21%IV0.46%PremiumMay 17, 2024Expiry Date2.58Intrinsic Value100Multiplier1DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type0.7861Delta0.0856Gamma32.26Leverage Ratio-0.3041Theta0.0036Rho25.36Eff Leverage0.0197Vega
Intraday
- 5D
- 1D
News
Descartes Systems Price Target Announced at $90.00/Share by Redburn Atlantic
Descartes Systems Price Target Announced at $90.00/Share by Redburn Atlantic
Descartes Systems Initiated at Neutral by Redburn Atlantic
Descartes Systems Initiated at Neutral by Redburn Atlantic
Redburn Atlantic Starts Descartes Systems Group With Neutral Rating
Descartes Systems Group (DSGX) has an average rating of outperform and price targets ranging from $75 to $110, according to analysts polled by Capital IQ.
Descartes' Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems
ATLANTA and LONDON, May 07, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (NASDAQ:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, released findings from Online Buying Grows,
Descartes Systems Group | 6-K: Report of foreign private issuer (related to financial reporting)
Weak Loonie? These TSX Stocks Could Gain Strength, Says RBC
Comments
Upgrades
• $AutoZone(AZO.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care(FMS.US$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US$ : Goldman Sachs Upgrades to Buy from Neutral - ...
• $AutoZone(AZO.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care(FMS.US$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US$ : Goldman Sachs Upgrades to Buy from Neutral - ...
22
Gainers:
• $Repare Therapeutics(RPTX.US$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US$ +10.2% (In reaction ...
• $Repare Therapeutics(RPTX.US$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US$ +10.2% (In reaction ...
19
$Descartes Systems Group(DSGX.US$ Sold out of my position at 8pct roi
$Descartes Systems Group(DSGX.US$ put in the other day at 55.15
1
3
But it is at a buy point right now and it’s my pick of the week for me. Will be doing a right up on it, will add you 
Read more